Biotech firm takes up 35,000 sq ft at L&G science park
Biotech company Amgen has taken up 35,000 sq ft at LGIM Real Assets’ Cambridge Science Park on a 10-year lease.
Amgen is relocating from one building to another within the park, which has been home to the company for more than 25 years.
It marks the biggest Cambridge deal of Q1 2020, according to Bidwells, who advised L&G.
Biotech company Amgen has taken up 35,000 sq ft at LGIM Real Assets’ Cambridge Science Park on a 10-year lease.
Amgen is relocating from one building to another within the park, which has been home to the company for more than 25 years.
It marks the biggest Cambridge deal of Q1 2020, according to Bidwells, who advised L&G.
Andrew Mercer, office sector lead at LGIM Real Assets, said: “We are delighted that Amgen has agreed to take a 10-year lease in Cambridge Science Park.
“This letting, agreed during the current lockdown on the March quarter-day, demonstrates the continued interest we are seeing in commercial space within technology and life science centres, despite ongoing uncertainty in the wider market.”
To send feedback, e-mail lucy.alderson@egi.co.uk or tweet @LucyAJourno or @estatesgazette